Compass Pathways Plc (CMPS)
11.26
-0.47
(-4.01%)
USD |
NASDAQ |
Jun 09, 16:00
11.23
-0.03
(-0.27%)
After-Hours: 20:00
Compass Pathways SG&A Expense (Quarterly) : 16.40M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Silence Therapeutics Plc | 7.026M |
| NuCana Plc | 2.113M |
| Mereo BioPharma Group Plc | 4.012M |
| Definium Therapeutics, Inc. | 17.74M |
| Immunocore Holdings Plc | 37.79M |